A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Status:
Completed
Trial end date:
2016-02-04
Target enrollment:
Participant gender:
Summary
To determine the dose or doses of PF-00547659 that will be the most effective to improve or
halt the disease symptoms in patients with moderate to severe ulcerative colitis.